Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395499 · ClinicalTrials.gov registry record
Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
A clinical trial of Patients Already Taking Risperidone for Clinical Indications, sponsored by Ohio State University.
- Completed
- Registry status
- 19
- Enrollment target
- 2
- Study locations
NCT00395499 is a study of Patients Already Taking Risperidone for Clinical Indications that has completed, run by Ohio State University. The registered enrollment target is 19 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT00395499, a study of Patients Already Taking Risperidone for Clinical Indications, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to: (1) examine the secrection of risperidone (RIS) (Risperdal) and its metabolite, 9-OH-RIS, in saliva, (2) determine the concentration ratio of RIS and 9-OH-RIS between plasma and saliva, and (3) compare the rate of decline in concentration of RIS and 9-OH-RIS in saliva and plasma by measurements at timed intervals during a single dosing interval.
Conditions Studied
Interventions
- DRUG Risperidone
Study Locations (2)
Ohio
- General Clinical Research Center - Columbus
- The Nisonger Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2001-05 |
| Est. Completion | 2003-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395499
The ClinicalTrials.gov registry entry for NCT00395499 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patients Already Taking Risperidone for Clinical Indications appearing as the primary indexed condition, and to 1 intervention - of which Risperidone is the first listed.
NCT00395499 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00395499 about?
NCT00395499 is a clinical study titled "Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva". The purpose of this research is to: (1) examine the secrection of risperidone (RIS) (Risperdal) and its metabolite, 9-OH-RIS, in saliva, (2) determine the concentration ratio of RIS and 9-OH-RIS between plasma and saliva, and (3) compare the rate of decline in concentration of RIS and 9-OH-RIS in sa...
What is the current status of trial NCT00395499?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2001-05. Estimated completion is 2003-04.
What conditions does trial NCT00395499 study?
This clinical trial studies the following conditions: Patients Already Taking Risperidone for Clinical Indications.
What interventions are being tested in trial NCT00395499?
The interventions under investigation include: Risperidone (DRUG).
Who is sponsoring clinical trial NCT00395499?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00395499 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.